• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2353295
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
55.44
9984.15
EPS(TTM)
Face Value()
Div & Yield %
19.54
10
0.46
 

Ambuja Cements consolidated net profit rises 78.47% in the March 2026 quarter
May 04,2026
Net profit of Ambuja Cements rose 78.47% to Rs 1830.15 crore in the quarter ended March 2026 as against Rs 1025.49 crore during the previous quarter ended March 2025. Sales rose 9.37% to Rs 10915.47 crore in the quarter ended March 2026 as against Rs 9980.55 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.88% to Rs 4728.18 crore in the year ended March 2026 as against Rs 4303.10 crore during the previous year ended March 2025. Sales rose 15.05% to Rs 40655.68 crore in the year ended March 2026 as against Rs 35336.44 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales10915.479980.55 9 40655.6835336.44 15
OPM %13.4118.71 -16.0816.90 -
PBDT1683.372431.18 -31 7169.728422.18 -15
PBT630.641737.33 -64 3599.316125.14 -41
NP1830.151025.49 78 4728.184303.10 10